"Dr. Michael Levin and team discovered that a specific #protein called hnRNP A1 does not function properly in [#MultipleSclerosis], causing neurodegeneration. In this study, the researchers will synthesize and screen for small molecule treatments that can target and rescue hnRNP A1 function to reduce #neurodegeneration and decrease disease severity in animal models of MS."
Saskatchewan Multiple Sclerosis Clinical Research Chair and Professor of Neurology & Anatomy, Physiology and Pharmacology
Thank you MS Canada and Saskatchewan Health Research Foundation (SHRF) for supporting our groundbreaking work on treatments for MS with a new 3-year grant! Learn more about the grant here: https://lnkd.in/epDABZsU